{"name":"Pliant Therapeutics, Inc.","slug":"pliant-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5qUUdvdE5DWVY3OTBRNVFqcnhqcGZ6LTZBT0NveXBvMmFVQWRzYWhtb3k4SGIzMjFRcUc5Mmd4MjNubmpTXzBtbXl3Wl92MzFRdmh3dGNZR19DRE0xV2ZsR1JmdGt0ZjFBclZvcGlR?oc=5","date":"2026-04-08","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Pliant Therapeutics, Inc. (PLRX) - Stock Titan","headline":"If You Invested $1,000 in Pliant Therapeutics, Inc. (PLRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOV2RXUmsxUHJhNWNLMFRJOER5eE5kT1ljSDliX2tzNHZ6MmRqazdLdVUzRDZMWWpUNE1pS2dxM2lZUEtjeW5XQTkzdmtLcVdpYW9qTmJlQVR1cV84enBvazV6ZjJNTDVRVGVBbUlNcVdYZ2hPXzhnS0FPM1BEem9pZlU2ckRjVkJKSEV0ZXZDbUk4MjZ2YlVJ?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+ - openPR.com","headline":"Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxOdm90RzFBMHJuOEwya29VbGhyb2dLMTRscWFmSzdjN0F2LVpGMENiYVE5MXZRbXIxdVNJMU84VXdQY04yREFZbkE4QmVjdlkxTVZEZzdSSF9xYzF1SGl4aDBRV2N3OW9qNU5uNzFRa09LZUJkWWVrQlJ0VHVPR0dnMFRmMDBQOF82ZTlKak94WUhCelhNeFFIa0ZkdlhzUHl4c3VEUlotWUxiMmxnNndhQUY2QVQ4TWxMeTRycTFIbFFqVlpMcHg3b0IwUE9Ya19hSmUwaElxaGdNWDNDRk5CVUxzb0N3R3p5dXQ1c21sanYzYXhWSmpJenkwUGxqUHRMTlpDMy1JYl9KV3B2dTZtU29kdzg4LXNaLXNWRkdGemZoa19pQTQ5aWlNbE50MmZwMFhfdlduZ3VlZVZ1Qk1WaV9VcVBLal9JaWN5U2VwMFdVLUl0?oc=5","date":"2026-02-26","type":"regulatory","source":"Barchart.com","summary":"Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics ","headline":"Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsig","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPMVF4ajR2Y0h1NWN0bzV1T3dXR0ItS3NsbnMwaDFYRjQwM1hWNFBLUWhyeFVMR01nYTZCZHM1UFlkbXhNMkRJMi1zQnlkQXlHUzRvV2cwR2NyOVhLb0V0RFJNdTF2VzJ0UkIyRDdVakdXTzhqbzR4RkdlcnVhNWZaTmVEMFdxTTB3T0pOQU1ZSldNbW1NV1lyVUJaOGRpemNKbkoxQzJ6OXlZNTR6d25JdHROXzkyOENZMlN0ZmRqQk4?oc=5","date":"2026-02-24","type":"patent","source":"Seeking Alpha","summary":"Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration - Seeking Alpha","headline":"Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-08","type":"pipeline","source":"simplywall.st","summary":"Penny Stocks To Watch With Market Caps Under $700M - simplywall.st","headline":"Penny Stocks To Watch With Market Caps Under $700M","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-15","type":"pipeline","source":"simplywall.st","summary":"3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st","headline":"3 Promising Penny Stocks With Market Caps Under $200M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPR0VsOWxyNmd3OTdZSEtzVTJlenFwamhIUmVweTExZVRLbUhHdUZ0UE5BVGVVZS1ILXptUnlnc2d2ZVZIek0tQUxqUFg3QUZpR0o3R0k2NkdfemhOblkxaXEzQ2dwQmdLS1ZTYWIyTk9seVg1b1dnQ21CNnd0QVpOTDJYaFlPMFdvRDJIMFBpc2w3ZTZ4U1o2SEhjbDBGQXhETFZFUHNPUFNYUXZhRTB4Mw?oc=5","date":"2025-05-02","type":"trial","source":"Fierce Biotech","summary":"Pliant Therapeutics cuts workforce by 45% after bexotegrast trial safety woes - Fierce Biotech","headline":"Pliant Therapeutics cuts workforce by 45% after bexotegrast trial safety woes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRHBDR094NFZsM3JoZWhsdTNrcWZDNkNGdFd0ZTEyYlpldWtEU0cxTHB5VUdLb0pRT0hfdENaT2x2ekxDMXhHNTdrQzhyakk0Zno1R1BCS19vUS1PcFpqb0JVZ05MMU8tR3ZKa2xIZDh5ZFpzaFpROE1aazJyQjM2QmlXZ3dmajcxSTRqemRIWElzc3dhV3NBbjVHN1pqSjRSM2I3cldB?oc=5","date":"2025-03-04","type":"trial","source":"Clinical Trials Arena","summary":"Pliant Therapeutics stock tumbles amid IPF trial cancellation - Clinical Trials Arena","headline":"Pliant Therapeutics stock tumbles amid IPF trial cancellation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOWnlJZzRWOWFleURiZ2prcjdRTGRpU3VVdV9WYkdoVE5iejFlc0hlSVYwYnFsbjdTRndDYmZmMklNTXFFcXM2WGVlbU9wdlNyeG96X3o3U2FTdFFHQXFBRDFOd1VPLXRwVGdYQ3NxMWhTS0tIdndNS29tRl9JVTlPZmJvZjVadmlac19EU1k2Yk9CRWNr?oc=5","date":"2025-02-10","type":"trial","source":"BioPharma Dive","summary":"Pliant shares collapse as company halts fibrosis drug study - BioPharma Dive","headline":"Pliant shares collapse as company halts fibrosis drug study","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZy1mWUlJQ190bEdDS19Wem8wNG01cXotbWlNSVFkc2lkdlQ4N2FDYWJ0RGhwbjJuQzdqaE9Bay1WNnN5WERoQWNjTDRLQ3UzblRfNW1RX0lBN1IzaGZHZVJlNlVXV1drVW9NNHBLM29LZkxIZXZjZmtMc0FkaUJ3NlY2NEVVRG5iZzE0M2FYd0lUMTFIRDFOZU1ObEt3TzBXZU4weEk0VWhsaFBnWThIUWpqc1lGNWpJdFE?oc=5","date":"2025-02-10","type":"trial","source":"BioSpace","summary":"Pliant Stock Crashes After Suspension of Idiopathic Pulmonary Fibrosis Study - BioSpace","headline":"Pliant Stock Crashes After Suspension of Idiopathic Pulmonary Fibrosis Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPakJlZEQ2bWItb2g0aG00ak5COWFyMV9ndldNWEh2SUc4YmRfRDhvSVNTQnRzUE5xMWFXNURhc1FreVZqYW9EN1ozc0prOHF0Rm9yUTgydGYyX21xU2pkaGhJSVpFemt6SlNxX3p2ejNSU01WNU1ZbXRDZ3I2VllBa29iRjhiTFBIdkE?oc=5","date":"2025-02-10","type":"trial","source":"pharmaphorum","summary":"Pliant slumps on decision to pause lung disease drug trial - pharmaphorum","headline":"Pliant slumps on decision to pause lung disease drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPODR6a0JUUjQ2d3pHa2c0M3gtN2ZRMDVGandaRFJha3VIMjg3OEdjWTRZTk1uMlV4Z3ktQUhXZGgxNW9oYmRPQ29NSlpwYklHenlyOElhTnhHTENKZldhZ1JiZ3RWU19CLW5vRUVGWEpneEs4dGY5V1gxRnhHanA2Ni1qQno5SnkyZG40dWxyYWVzVFM4Z2hKaHJqTlg2OEkzTnhMd0hveW5vdEhiRENMVEFxTlVtV1ZwejdjVHhnVlYtR1lhbDVuRzU3YlVETDR3bjhhZm40LWVNcUpKQVdpY2FHZl9JTWQ2VDVRR19KdjFVd1o5RUQzOERDMkZQcEpLWTNwZVJtcjgzR2ppYUJRS01kMnUxOUpLSDlwWFVHT19EaVZDSFhaS2F5cHpNa0MwZjcwVXY1X0dSejgwNUE?oc=5","date":"2025-01-28","type":"trial","source":"GlobeNewswire","summary":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire","headline":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}